Patient Case 1: The Typical Psoriasis Patient

Experts discuss a hypothetical patient case of a 47-year-old man with moderate-to-severe psoriasis. He is on secukinumab and still experiences flares and significant psychosocial burden. Experts note this "Joe Psoriasis" scenario is common, where partial response leaves patients frustrated. Key initial steps discussed include assessing adherence, dosing frequency, and whether the loss of response is primary or secondary.

Management follows a structured approach, aligning with National Psoriasis Foundation guidelines for reassessment at three and six months. For optimization, clinicians may consider off-label dosing adjustments before switching therapies. The decision to switch depends on response history: secondary failures may allow a change within the same drug class, while primary failures often warrant switching to a different mechanistic class. The abundance of modern options makes switching a more feasible and confident strategy than in the past.